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FAST TRACK
Frequent PVCs are 
linked to acute MI 
and sudden death 
in patients without 
known coronary 
artery disease
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Should you evaluate for CAD 
in seniors with premature 
ventricular contractions? 
  Evidence-based answer
Yes. Current guidelines suggest 
evaluating patients with premature 
ventricular contractions (PVCs) and 
associated risk factors for underlying 
coronary artery disease (strength of 
recommendation [SOR]: C, expert 
opinion). 
 Frequent PVCs are associated with 
acute myocardial infarction and sudden 
death in patients without known coronary 
artery disease (CAD). They are linked to 
increased mortality from all causes in 
elderly patients with a history of CAD, left 
ventricular dysfunction, hypertension, or 
valvular heart disease. Frequent PVCs 
during recovery from exercise stress 
testing are also associated with increased 
mortality. 
 There is strong evidence against 
suppressing PVCs with antiarrhythmics 
(SOR: A, randomized controlled trials 
[RCTs]).
Stress preventive measures 
I fi nd myself discussing PVCs most 
often with young women who don’t have 
known heart disease—rather than the 
elderly. I often discover PVCs on physical 
examination in the offi ce or see them on 
a Holter monitor ordered to rule out other 
more worrisome arrhythmias. 
 This reminds me that I need to not only 
consider the issue of treatment aimed at 
suppressing PVCs (not helpful except when 
the patient has signifi cant symptoms), but 
also to consider whether the patient has 
risk factors for CAD. 
 In future discussions with patients 
about PVCs, I plan to shift the focus to 
measures to prevent CAD—specifi cally 
tobacco cessation, weight management, 
daily physical activity, and a healthy 
diet.  
Jennifer Lochner, MD
Oregon Health and Sciences University, Portland
Clinical commentary
❚ Evidence summary 
A consistent defi nition of frequent PVCs 
doesn’t exist in the literature. Some stud-
ies have found a signifi cant risk of death 
or acute myocardial infarction associated 
with >30 PVCs per hour.1,2 The 2006 
American College of Cardiology/Ameri-
can Heart Association/European Society 
of Cardiology guideline defi nes frequent 
PVCs as >10 per hour.3 
Despite the association between fre-
quent PVCs and increased risk of death 
and cardiac events, our review didn’t 
fi nd studies that indicate the utility of 
evaluation strategies for higher-risk 
patients.
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Frequent PVCs predict 
increased mortality 
The Framingham study looked at the 
prognostic implications of frequent PVCs 
(>30 per hour) in a cohort of symptom-
atic patients examined over a 6-year pe-
riod.1 Men, but not women, had a signifi -
cant increase in all-cause mortality (rela-
tive risk [RR]=2.36; 95% confi dence 
interval [CI], 1.65-3.2) and myocardial 
infarction or sudden death (RR=2.12; 
95% CI, 1.33-3.38). The Copenhagen 
Holter study of a cohort of healthy pa-
tients demonstrated an increased risk of 
myocardial infarction or cardiovascular 
death in patients with >30 PVCs per 
hour (hazard ratio [HR]=2.85, 95% CI, 
1.16-7.0).2 
Frequent PVCs occurring during 
recovery from stress testing are also 
associated with increased mortality. 
A large prospective cohort study fol-
lowed more than 29,000 patients with 
varying degrees of risk for 5 years. Af-
ter adjusting for confounding variables, 
frequent PVCs (≥7 per minute or more 
complex ventricular ectopy) during 
recovery predicted an increased risk 
of death (HR=1.5; 95% CI, 1.1-1.9). 
Frequent PVCs arising during exercise 
stress testing were not associated with 
increased risk.4
Suppressing PVCs is a bad idea
Studies have evaluated whether suppress-
ing PVCs with antiarrhythmic agents 
improves prognosis. Both Cardiac Ar-
rhythmia Suppression Trials (CAST I: 
encainide and fl ecainide; CAST II: mori-
cizine) showed that suppressing frequent 
PVCs signifi cantly increased mortality in 
the treatment groups.5,6 
Recommendations 
In 2006, the American College of Cardi-
ology, American Heart Association, and 
European Society of Cardiology pub-
lished their Guidelines for Management 
of Patients with Ventricular Arrhythmias 
and the Prevention of Sudden Cardiac 
Death.3  
The TABLE summarizes characteris-
tics of patients with PVCs who were at 
higher risk of underlying cardiac disease 
and death. All patients with PVCs should 
have a history and physical examination, 
electrocardiogram, and electrolyte studies. 
Higher-risk patients should be considered 
for further evaluation, including stress test-
ing, echocardiography, and ambulatory 
electrocardiogram (SOR: C, opinion). ■
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There is strong 
evidence against 
suppressing 
PVCs with 
antiarrhythmics
Characteristics of patients with PVCs 
who are at higher risk of cardiac disease/death 
PATIENT 
CHARACTERISTICS LOWER RISK HIGHER RISK
Morphology Unifocal PVCs
<10 PVCs per hour
Complex multifocal PVCs
Ventricular tachycardia
Ventricular fi brillation
>10 PVCs per hour
Symptoms Asymptomatic Palpitations
Presyncope
Syncope
Preexisting 
conditions
None Known history of CAD
Structural heart disease
  Valvular heart disease
  Cardiomyopathy
CAD, coronary artery disease, PVCs, premature ventricular contractions.
Source: American College of Cardiology et al.3
TABLE
